Wednesday, September 26, 2007

FDA Reforms

According to an article in Forbes magazine the recent passing of the FDA Amendments Act of 2007 is the biggest overhaul of the FDA in decades. The Consumers Union called it 'the most significant prescription drug safety reforms in 45 years'. Central to the new legislation is new funding and oversight of drug safety and risk minimization. The legislation also codifies the post phase 1 clincal trials database, conflict of interest for advisory committee members, and $25 million for the FDA to perform routine active surveillance.

All-in-all we may be headed towards a safer (though never totally safe) world.

No comments: